Effects of Anonaine on Dopamine Biosynthesis and L-DOPA-Induced Cytotoxicity in PC12 Cells

Effects of Anonaine on Dopamine Biosynthesis and L-DOPA-Induced Cytotoxicity in PC12 Cells

The effects of anonaine, an aporphine isoquinoline alkaloid, on dopaminebiosynthesis and L-DOPA-induced cytotoxicity in PC12 cells were investigated. Anonaineat concentration ranges of 0.01-0.2 ÃŽÂ¼M showed a significant inhibition of dopaminecontent at 24 h, with an IC50 value of 0.05 ÃŽÂ¼M. Anonai...

Full description

Bibliographic Details
Main Authors:	Myung Koo Lee, Sung Cil Lim, Shi Yong Ryu, Young Kyoon Kim, Chun Mei Jin, Jae Joon Lee
Format:	Article
Language:	English
Published:	MDPI AG 2008-02-01
Series:	Molecules
Subjects:	Anonaine Dopamine biosynthesis L-DOPA-induced cytotoxicity PC12 cells.
Online Access:	http://www.mdpi.com/1420-3049/13/2/475/

Similar Items

The Pharmacological Activities of (−)-Anonaine
by: Chung-Yi Chen, et al.
Published: (2013-07-01)

1-O-Hexyl-2,3,5-Trimethylhydroquinone Ameliorates l-DOPA-Induced Cytotoxicity in PC12 Cells
by: Hyun Jin Park, et al.
Published: (2019-03-01)

On dopamine neurons : nerve fiber outgrowth and L-DOPA effects
by: af Bjerkén, Sara
Published: (2008)

Suppressive Effect of Tetrahydrobiopterin on L-β-( 3,4-Dihydroxyphenyl) alanine-Induced Cytotoxicity in PC-12 Cells
by: Kojima Shuji, et al.
Published: (1997-01-01)

Nicotine-mediated improvement in l-dopa-induced dyskinesias in MPTP-lesioned monkeys is dependent on dopamine nerve terminal function
by: Maryka Quik, et al.
Published: (2013-02-01)

Chronic L-DOPA therapy alters central serotonergic function and L-DOPA-induced dopamine release in a region-dependent manner in a rat model of Parkinson's disease
by: Sylvia Navailles, et al.
Published: (2011-02-01)

6R-L-erythro-5,6,7,8-Tetrahydrobiopterin and Dopamine Release
by: Miwa Soichi, et al.
Published: (1995-11-01)

Dysfunction in the nigrostriatal system : effects of L-DOPA and GDNF
by: Nevalainen, Nina
Published: (2013)

Reciprocal interaction between monoaminergic systems and the pedunculopontine nucleus: Implication in the mechanism of L-DOPA
by: Giuseppe Di Giovanni, et al.
Published: (2019-08-01)

Serotonergic neurons mediate ectopic release of dopamine induced by l-DOPA in a rat model of Parkinson's disease
by: Sylvia Navailles, et al.
Published: (2010-04-01)

Dopamine D3 Receptor Plasticity in Parkinson’s Disease and L-DOPA-Induced Dyskinesia
by: Kathryn Lanza, et al.
Published: (2021-03-01)

5-Hydroxy-tryptophan for the treatment of l-DOPA-induced dyskinesia in the rat Parkinson's disease model
by: Elisabetta Tronci, et al.
Published: (2013-12-01)

Comparative analysis of Anopheles gambiae L-tyrosine decarboxylase and L-DOPA decarboxylase
by: Aljabri, Hareb Mohammed
Published: (2014)

Synergistic effects of dopamine and Zn2+ on the induction of PC12 cell death and dopamine depletion in the striatum: possible implication in the pathogenesis of Parkinson's disease
by: Hsiao-Sui Lo, et al.
Published: (2004-10-01)

A30P α-synuclein impairs dopaminergic fiber regeneration and interacts with L-DOPA replacement in MPTP-treated mice
by: Éva M. Szegő, et al.
Published: (2012-01-01)

L-Dopa and Brain Serotonin System Dysfunction
by: Branden J. Stansley, et al.
Published: (2015-03-01)

Regulation of dopamine neurotransmission from serotonergic neurons by ectopic expression of the dopamine D2 autoreceptor blocks levodopa-induced dyskinesia
by: Rhyomi C. Sellnow, et al.
Published: (2019-01-01)

The Multimodal Serotonergic Agent Vilazodone Inhibits L-DOPA-Induced Gene Regulation in Striatal Projection Neurons and Associated Dyskinesia in an Animal Model of Parkinson’s Disease
by: Feras Altwal, et al.
Published: (2020-10-01)

Extrastriatal monoamine neuron function in Parkinson’s disease: An 18F-dopa PET study
by: Robert Y. Moore, et al.
Published: (2008-03-01)

Effects of L-dopa priming on cortical high beta and high gamma oscillatory activity in a rodent model of Parkinson's disease
by: Kristin B. Dupre, et al.
Published: (2016-02-01)

Biosynthesis of Copper Oxide (CuO) Nanowires and Their Use for the Electrochemical Sensing of Dopamine
by: Sasikala Sundar, et al.
Published: (2018-10-01)

Serotonin system implication in L-DOPA-induced dyskinesia: from animal models to clinical investigations
by: Manolo eCarta, et al.
Published: (2014-05-01)

Persistent activation of the D1R/Shp-2/Erk1/2 pathway in l-DOPA-induced dyskinesia in the 6-hydroxy-dopamine rat model of Parkinson's disease
by: Chiara Fiorentini, et al.
Published: (2013-06-01)

l-DOPA and Its Receptor GPR143: Implications for Pathogenesis and Therapy in Parkinson’s Disease
by: Yoshio Goshima, et al.
Published: (2019-10-01)

Combination Treatment of Icariin and L-DOPA Against 6-OHDA-Lesioned Dopamine Neurotoxicity
by: Di-Sheng Lu, et al.
Published: (2018-05-01)

Clinical and Genetic Heterogeneity in a Cohort of Chinese Children With Dopa-Responsive Dystonia
by: Yan Chen, et al.
Published: (2020-02-01)

Dopamine synthesis and dopamine receptor expression are disturbed in recurrent miscarriages
by: Michael J Gratz, et al.
Published: (2018-05-01)

Corrigendum: Combination Treatment of Icariin and L-DOPA Against 6-OHDA-Lesioned Dopamine Neurotoxicity
by: Di-Sheng Lu, et al.
Published: (2020-10-01)

Intrastriatal inhibition of aromatic amino acid decarboxylase prevents l-DOPA-induced dyskinesia: A bilateral reverse in vivo microdialysis study in 6-hydroxydopamine lesioned rats
by: Kerstin Buck, et al.
Published: (2008-02-01)

Ventral striatal dopamine synthesis capacity predicts financial extravagance in Parkinson’s Disease
by: Andrew David Lawrence, et al.
Published: (2013-02-01)

Inhibited Dopamine Synthesizing Cell Model of AADC Deficiency
by: Melati Khalid, et al.
Published: (2019-06-01)

Relationship between L-DOPA-induced reduction in motor and exploratory activity and degree of DAT binding in the rat
by: Susanne eNikolaus, et al.
Published: (2014-12-01)

Parkinson’s Disease-Associated Melanin Steal [Expression of Concern]
by: Hinz M, et al.
Published: (2020-04-01)

Antiparkinson Prodrugs
by: Laura Serafina Cerasa, et al.
Published: (2008-01-01)

Parkinson’s Disease-Associated Melanin Steal [Retraction]
by: Hinz M, et al.
Published: (2021-03-01)

TRH Analog, Taltirelin Improves Motor Function of Hemi-PD Rats Without Inducing Dyskinesia via Sustained Dopamine Stimulating Effect
by: Cong Zheng, et al.
Published: (2018-11-01)

Striatal signaling in L-DOPA-induced dyskinesia: common mechanisms with drug abuse and long term memory involving D1 dopamine receptor stimulation
by: Mario Gustavo Murer, et al.
Published: (2011-08-01)

Bio-Functional Constituents from the Stems of Liriodendron tulipifera
by: Chung-Yi Chen, et al.
Published: (2012-04-01)

Relations entre les dyskinésies L-dopa induites et le récepteur D1 de la dopamine dans les neurones striataux : étude expérimentale et perspectives en thérapeutique
by: Berthet, Amandine
Published: (2010)

The anti-dyskinetic effect of dopamine receptor blockade is enhanced in parkinsonian rats following dopamine neuron transplantation
by: Eunju Shin, et al.
Published: (2014-02-01)